RXRX — Recursion Pharmaceuticals, Inc. stock price, charts and financials

QT17Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.31
+0.13+4.09%
OverviewShort InterestFilings
RXRXQT17Recursion Pharmaceuticals, Inc.·NASDAQ
3.31+4.09%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 09, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 515
Page
▼
/ 21